Profile data is unavailable for this security.
About the company
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.
- Revenue in USD (TTM)1.15bn
- Net income in USD202.97m
- Incorporated1981
- Employees3.05k
- LocationBio-Techne Corp614 MCKINLEY PL N EMINNEAPOLIS 55413United StatesUSA
- Phone+1 (612) 379-8854
- Fax+1 (612) 656-4400
- Websitehttps://www.bio-techne.com/
Mergers & acquisitions
Acquired company | TECH:NSQ since announced | Transaction value |
---|---|---|
Lunaphore Technologies SA | -6.10% | -- |